108 related articles for article (PubMed ID: 6946208)
1. Salivary composition, phenytoin ingestion and gingival overgrowth.
Smith QT; Hamilton MJ
J Periodontol; 1981 Nov; 52(11):673-9. PubMed ID: 6946208
[TBL] [Abstract][Full Text] [Related]
2. Salivary and plasma IgA of seizure subjects receiving phenytoin.
Smith QT; Hamilton MJ; Biros MH; Pihlstrom BL
Epilepsia; 1979 Feb; 20(1):17-23. PubMed ID: 421674
[TBL] [Abstract][Full Text] [Related]
3. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
Ball DE; McLaughlin WS; Seymour RA; Kamali F
J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin-induced gingival overgrowth control in severely retarded children.
Steinberg SC; Steinberg AD
J Periodontol; 1982 Jul; 53(7):429-33. PubMed ID: 6956708
[TBL] [Abstract][Full Text] [Related]
5. [Salivary secretion and gingival hyperplasia in diphenyl hydantoin-treated guinea pigs].
Westphal P
Sven Tandlak Tidskr; 1969 Aug; 62(8):505-8. PubMed ID: 5267695
[No Abstract] [Full Text] [Related]
6. Antimicrobial proteins in human unstimulated whole saliva in relation to each other, and to measures of health status, dental plaque accumulation and composition.
Rudney JD; Krig MA; Neuvar EK; Soberay AH; Iverson L
Arch Oral Biol; 1991; 36(7):497-506. PubMed ID: 1776923
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin induced gingival overgrowth in institutionalized epileptics.
Hassell T; O'Donnell J; Pearlman J; Tesini D; Murphy T; Best H
J Clin Periodontol; 1984 Apr; 11(4):242-53. PubMed ID: 6584450
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia.
Kirstilä V; Lenander-Lumikari M; Söderling E; Tenovuo J
Acta Odontol Scand; 1996 Dec; 54(6):391-7. PubMed ID: 8997439
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model.
Nishikawa S; Nagata T; Morisaki I; Oka T; Ishida H
J Periodontol; 1996 May; 67(5):463-71. PubMed ID: 8724703
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin do not alter the effects of bacterial and amplified plaque extracts on cultures of fibroblasts from normal and overgrown gingivae.
Smith QT; Hinrichs JE
J Dent Res; 1987 Aug; 66(8):1393-8. PubMed ID: 3476609
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin and other markers from gingival crevicular fluid and saliva before and after periodontal treatment.
Jentsch H; Sievert Y; Göcke R
J Clin Periodontol; 2004 Jul; 31(7):511-4. PubMed ID: 15191585
[TBL] [Abstract][Full Text] [Related]
12. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice.
Thomason JM; Seymour RA; Rawlins MD
Community Dent Oral Epidemiol; 1992 Oct; 20(5):288-91. PubMed ID: 1424550
[TBL] [Abstract][Full Text] [Related]
13. Gingival overgrowth in partially edentulous ridges in an elderly female patient with epilepsy: a case report.
Dhingra K; Prakash S
Gerodontology; 2012 Jun; 29(2):e1201-6. PubMed ID: 22612838
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin-induced gingival overgrowth in rats infected with Streptococcus sobrinus 6715.
Morisaki I; Mihara J; Kato K; Kitamura K; Adachi C; Sobue S; Hamada S
Arch Oral Biol; 1990; 35(9):753-8. PubMed ID: 2151111
[TBL] [Abstract][Full Text] [Related]
15. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F
J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
[TBL] [Abstract][Full Text] [Related]
16. Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth.
Yamada H; Nishimura F; Furuno K; Naruishi K; Kobayashi Y; Takashiba S; Murayama Y
J Int Acad Periodontol; 2001 Apr; 3(2):42-7. PubMed ID: 12666977
[TBL] [Abstract][Full Text] [Related]
17. The effect of parotid salivary flow rate on the levels of salivary antimicrobial proteins in patients with Sjögren's syndrome.
Zipp MM; Yasbin L; al-Hashimi I
Quintessence Int; 1999 Oct; 30(10):700-5. PubMed ID: 10765854
[TBL] [Abstract][Full Text] [Related]
18. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia.
Iacopino AM; Doxey D; Cutler CW; Nares S; Stoever K; Fojt J; Gonzales A; Dill RE
J Periodontol; 1997 Jan; 68(1):73-83. PubMed ID: 9029455
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of thiocyanate, hypothiocyanite, 'free' and 'total' lysozyme, lactoferrin and secretory IgA in resting and stimulated whole saliva of children aged 12-14 years and the relationship with plaque accumulation and gingivitis.
Jalil RA; Ashley FP; Wilson RF; Wagaiyu EG
J Periodontal Res; 1993 Mar; 28(2):130-6. PubMed ID: 8478785
[TBL] [Abstract][Full Text] [Related]
20. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation.
Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
